Jun 15, 2021 / 05:30PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
Okay. Welcome to the second day of the BofA Virtual Napa Conference. We really do wish this was actual Napa. This is our second annual virtual Napa, which is -- which I'd rather be there, but that's okay.
My name is Geoff Meacham. I'm the senior biopharma analyst. We have Bill Maughan from my team as well. And we're thrilled to have Royalty Pharma with us today and we have 3 executives from left to right, Terrance Coyne, Chief Financial Officer. We have Chris Hite, Executive VP and Vice Chairman; and Jim Reddoch, Executive VP, Co-Head of Research and Chief Scientific Officer. Guys, welcome.
Terrance Coyne - Royalty Pharma plc - Executive VP & CFO
Geoff, great to be here. Thanks for having us.
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
Yes, of course. So Terry, maybe just kick it over to you to give kind of a high-level background to Royalty Pharma. We have a lot of questions here
Royalty Pharma PLC at Bank of America NAPA Healthcare Conference Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers